Blog - Page 3611 of 5588

MondaySep 13, 2010 10:03 am

Evolution Petroleum Corp. (EPM) Releases Operational Update

Evolution Petroleum Corp. released an update on its oil and gas exploration and development activities, including reserve information, for the fiscal year ending June 30, 2010. Evolution Petroleum Corporation reported that the company had proved reserves of 12.4 million barrels oil equivalent (BOE) as of 7/1/2010. The company reported proved reserves of 3.0 million BOE a year earlier. Evolution Petroleum Corporation attributed the increase in proved reserves to the inclusion of reserves at the company’s properties at the Delhi Field. The Delhi Field is an enhanced oil recovery project operated by Denbury Resources (DNR), where carbon dioxide is injected into…

MondaySep 13, 2010 9:44 am

Ocean Power Technologies, Inc. (OPTT) Awarded $4.8 Million by US Department of Energy

Ocean Power Technologies Inc. is a pioneer in wave-energy technology that harnesses ocean waves to generate reliable and clean electricity. The company's proprietary PowerBuoy system is based on modular, ocean-going buoys that capture and covert wave energy into electricity. OPTT has over a decade of experience in this sector of renewable energy. The company announced today that it has won two new funding awards totaling $4.8 million from the US Department of Energy. Ocean Power Technologies plans to use the first award, for $2.4 million, in connection with the construction and deployment of one of its 150 kilowatt PB150 PowerBuoys…

MondaySep 13, 2010 9:38 am

Pro-Pharmaceuticals, Inc. (PRWP.OB) Announces Collaboration with Numoda to Increase DAVANAT’s Speed-to-Market

Pro-Pharmaceuticals, Inc. is engaged in the discovery, development and commercialization of therapeutics that target Galectin receptors for the advanced treatment of cancer. Today, Pro-Pharmaceuticals took a major step with the announcement they have collaborated with Numoda to manage the Phase III clinical trial of DAVANAT®. The combination of Pro-Pharmaceuticals and Numoda appears to be a winning one. DAVANAT is Pro-Pharmaceuticals’ lead product candidate and has excelled with the 100 cancer patients it was tested on. As for Numoda, the company is regarded as the world's most innovative and complete technology solutions provider in the life sciences industry. When asked what…

MondaySep 13, 2010 9:17 am

Hana Biosciences, Inc. (HNAB.OB) Reverse Stock Split Becomes Effective Today

Hana Biosciences, Inc., a biopharmaceutical company that focuses on cancer care, has instated a 1 for 4 reverse split of its common stock. The split was previously authorized by stockholders at a special meeting on September 2nd, 2010. As a result of the reverse split, every four shares of Hana's pre-split common stock was automatically reclassified as and combined into one share of post-split common stock. As a result, the number of outstanding shares of common stock is approximately 21.2 million, excluding outstanding stock options and warrants to purchase common stock, and subject to adjustment for fractional shares. The reverse…

MondaySep 13, 2010 9:12 am

Ruby Creek Resources, Inc. (RBYC.OB) Signs Purchase Agreement for Kapinga Property

Ruby Creek Resources, Inc., an exploration and mining company, now has rights to an additional 340 Sq Km in one of Tanzania’s largest alluvial Goldfields. The Company already has a majority of its holdings in Tanzania. Should Ruby Creek decide to exercise its right, the new property would be acquired at the purchase price of $500,000. The property is located directly adjacent and south of the Ruby Creek Mkuvia Gold Project in southern Tanzania. Payments for the property are set up to be staged, first payment of $250,000 upon purchase and remaining $250,000 will be made when the first mining…

MondaySep 13, 2010 8:59 am

Harrington West Financial Group, Inc. (HWFG.OB) Files for Chapter 11

Harrington West Financial Group, Inc. has decided to file for Chapter 11 bankruptcy protection and liquidate its assets. The case was filed in the United States Bankruptcy Court, Central District of California, Northern Division. A plan for liquidation will be released in a few months. Looking at the history of the stock, this event did not come as a surprise. HWFG has been on a downward slide for the last 3 months. Earlier this summer, an Entry of a Prompt Corrective Action Directive (“PCA Directive”) was announced. The PCA Directive outlines guidelines for reporting to the OTS on the status…

MondaySep 13, 2010 8:22 am

VizStar, Inc. (VIZS.OB) CEO Issues Shareholder Letter Detailing Future Plans

Earlier this morning, VizStar, Inc.'s CEO, Gary Clyburn Jr., issued a letter to the investment community outlining the Company's current positioning, growth strategy and pending developments. The letter is presented below in its entirety. Dear present and many future VizStar shareholders, In the near future, we will be changing our name to Celestial Jets to better reflect our business operations. We are a private jet company that is using state of the art telecommunications technology to provide on-demand private jet service to a large and lucrative market, the upper income individual. This multi-billion dollar market is best represented by the…

MondaySep 13, 2010 8:01 am

CytRx Corporation (CYTR) Video Chart for Monday, September 13, 2010

CYTR is trying to make a move off a support level. The indicators are aligned to support this movement. We will be closely watching the support, resistance and trendlines as described in the video. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

FridaySep 10, 2010 3:55 pm

Aceto Corp. (ACET) Posts Q4, FY 2010 Financial Results; Announces Key Management Changes

Aceto Corp. operates in ten countries as a global leader in sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products. The company today posted its financial results and business highlights for the fiscal fourth quarter and year ended June 30, 2010. The company reported net sales for the fiscal 2010 fourth quarter at $105.8 million, up 41.4 percent from $74.8 million reported in the fourth quarter of 2009, representing record quarterly sales in Aceto's history. Gross profit for the fourth quarter of 2010 increased 34.4 percent to $15.7 million as compared to…

FridaySep 10, 2010 2:21 pm

JA Solar Holdings Co., Ltd. (JASO) Signs RMB 30B Agreement with China Development Bank

JA Solar, www.jasolar.com – a global leader in high-performance solar cells and modules, today reported signing of a Financial Partnership Agreement with the Shanghai branch of the Chinese central government’s solely owned policy bank, China Development Bank (CDB). The agreement constitutes a rather symbiotic operational framework for collaborative efforts between CDB and JASO while developing the Company’s long-term growth strategy, and provides up to RMB 30B of financing and credit facility towards that end. Internal CDB risk management and operational regulations (subject to individual credit and lending agreements) will ultimately determine the discrete details of terms for the credit facilities,…

Site Search

Company Search